Authors
Latest:
ESG is Reshaping the Supply ChainSix steps pharma organizations can follow to help achieve sustainability in their product supply chains
Latest:
Disruption without interruption: Transitioning Rare Disease HUB & NCP ProgramsTransitioning a rare disease HUB or NCP program to a rare-focused partner can yield major service quality improvements without program disruption.
Latest:
Rethinking Pharma Commercialization Models as Healthcare EvolvesHow cross-functional commercialization teams can hone their role within clinical management pathways, communicate value to all stakeholders, achieve excellence in evidence generation, and maximize the opportunities of digital technologies
Latest:
Pharma Strategies for Succeeding Amid Strong HeadwindsCompanies striving for transformed and targeted growth are exploring strategies that include partnerships, artificial intelligence, increased efficiencies, and competitive intelligence.
Latest:
The Digital Transformation Reshaping Hospitals and Medication ManagementDespite challenges surrounding communication overload, drug shortages, and cybersecurity risks, this term is revolutionizing medication management and patient care through the use artificial intelligence and predictive forecasting.
Latest:
Empowering Patients in Oncology TrialsCreating positive experiences and other patient-focused strategies for sponsors to consider when planning and executing cancer studies
Latest:
The Value of ML in Customer TargetingHow biopharma commercial teams can leverage machine learning techniques to improve targeting of HCPs and patients
Latest:
Commercializing Cell and Gene Therapies in CanadaSandra Anderson outlines what manufacturers need to know about the regulatory environment and commercialization solutions for the Canadian market.
Latest:
Your Engagement Strategy is Only as Good as Your DataLeaders from Janssen, Novartis Gene Therapies, Pierre Fabre, and the German cancer app start-up Mika discuss how they are leveraging data in innovative ways to advance their engagement with the scientific community and their overall commercial operations
Latest:
Building a Robust Cold Chain for CGTsStrategies to boost the reproducibility and traceability of cell and gene therapies for more effective clinical studies and commercialization
Latest:
Navigating the Landscape of Global AI GovernanceThe importance of embracing universal values and business models that prioritize humanity.
Latest:
QProducts & Services Talks Sustainability at LogiPharmaKevin Lynch, Vice President of Global Sales at QProducts & Services, dives into the role of sustainability in pharmaceutical packaging.
Latest:
Getting to answers about Biogen’s AduhelmExploring RCT, RWE and alternative study designs as a path forward
Latest:
Community Pharmacies in Crisis: Navigating the Challenges and ClosuresWith today's pharmacy landscape shaken by unprecedented and wider disruption to healthcare support and delivery, community and independent entities strive to remain an integral cog in the mix.
Latest:
Tapping the Value of Conscientious StewardshipWhy it's critical for companies to set long-term, strategic goals in their journeys toward decarbonization.
Latest:
Advancing PV Operations and Patient Safety through InnovationHow digital adoption is driving pharmacovigilance
Latest:
The State of Patient Support Services in Today’s LandscapeWhy these programs require a hybrid approach that combines technology and human connection.
Latest:
Boosting Patient Adherence: The Power of Clinical Support ProgramsIn this podcast, we speak with Amanda Scholz, UBC Senior Clinical Program Manager, MHA, BSN, RN as we discuss the important role that clinical adherence programs play in empowering patients and bolster persistence to prescribed life-changing medications throughout their journey.
Latest:
Strategic Transformation of a Global Medical Information ProgramThe consolidation of global medical information services is a multi-faceted endeavor with numerous challenges. Real-life examples of how multinational firms can manage the headwinds to develop flexible roadmaps for success can assist others in their journey.
Latest:
Effective patient-first approach in rare disease relies on true sales—not channel stockingHow the development of more quantitative and qualitative data around the patient can drive better-informed care decisions—and help avoid potential overstock scenarios that can deplete earnings
Latest:
Three Key Pharmaceutical Logistics Challenges to MonitorVarious forms of technology—including in the serialization and refrigeration spaces—are necessary in order to keep goods flowing smoothly through the supply chain.
Latest:
Navigating Access and Reimbursement Through UncertaintyA forum intended for HCPs, policy experts, and industry leaders addresses pressing obstacles facing this sector of the industry today.
Latest:
From Challenges to Solutions: Breaking Barriers to Revolutionize Patient ServicesA guide to overcoming the top obstacles facing patient services programs today.
Latest:
The Prominence of Pharmacy DesertsHow chain and local closures are impacting healthcare access.
Latest:
FDA Offers 12-Month DSCSA Stabilization Period, but Urges Industry Not to DelayA breakdown on the decision, and how to navigate these obstacles using a network approach.
Latest:
Remaking the Trial Medication Adherence SpaceIQVIA informs us, new prescriptions for chronic therapies were 20% below what they were before 2020 and telemedicine patient encounters have settled at 10%. Accenture informs us, the low point of in-person pharma rep sales calls over the last year was 35%. These three facts point to lower access to trial medication and give strong impetus for remaking the trial medication adherence space. The CDC informs us that medication non-adherence causes up to 125,000 preventable deaths and $100 billion to 300 billion in preventable medical costs each year. Trial medication is a key solution to medication adherence. Pharmaceutical Commerce asked Hal Walsh, CEO of SymmetryRx, to tell us about the latest digital solutions that truly streamline the route from the manufacturer to the hands of patients in today’s high-tech, low-touch world.
